The “Hard 20” in New Zealand Isn’t a Deadline—It’s a Strategy.
In drug development and generic competition, timelines are often discussed like weather: unpredictable, shifting, and occasionally stormy. But in New Zealand, one rule behaves more like gra…

Most people in pharma think they understand “patent dates.” They don’t.
If you work in drug development, regulatory strategy, or commercial planning, you’ve probably seen it: a spreadsheet with a clean-looking “patent expiry” date—followed by a scram…

Pharma has a patent problem—and it’s not just about litigation.
For years, the industry has treated IP as a purely legal asset: file early, defend aggressively, extend where possible, and monetize through exclusivity. But the modern “patent box” conver…

180 Days: The Generic Launch Window That Can Make (or Break) Your Entire Strategy
There’s a moment in every generic drug launch when the calendar stops being “background noise” and becomes a weapon.
It’s the 180-day exclusivity period—a statutory windo…

How do drug development investments affect lurbinectedin’s cost? Drug pricing for medicines like lurbinectedin is… https://www.Drugchatter.com/chat/1491/what-role-does-drug-development-investment-play-in-lurbinectedin’s-cost/

What exact date did the FDA first approve Keytruda (pembrolizumab)? Keytruda (pembrolizumab) received its first FDA approval… https://www.Drugchatter.com/chat/26764/what’s-the-exact-date-of-keytruda’s-first-fda-approval/

What happens if Keytruda’s side effects worsen over time? Keytruda, an immunotherapy medication used to treat various… https://www.Drugchatter.com/chat/31553/can-keytruda’s-side-effects-worsen-over-time/

When does trastuzumab emtansine’s patent expire, and what does that mean for prices? Patent expiry affects prices… https://www.Drugchatter.com/chat/47513/how-does-trastuzumab-emtansine’s-patent-expiry-affect-drug-prices/

Managing Aspirin’s Interaction with Blood Thinners: What You Need to Know Aspirin is a common medication used to prevent… https://www.Drugchatter.com/chat/26400/can-aspirin’s-interaction-with-blood-thinners-be-managed/

When Will Exclusivity Expire on Ruxolitinib? Ruxolitinib, marketed under the brand name Jakafi, is a disease-modifying antirheumatic… https://www.Drugchatter.com/chat/41682/has-ruxolitinib’s-generic-entry-led-to-significant-cost-reductions/